Advisory Board January 23, 2025

According to a new study published in Nature Medicine, GLP-1 drugs were associated with a decreased risk of 42 health conditions, including Alzheimer’s disease. However, the drugs were also associated with an increased risk of 19 other health conditions.

What the future of weight management drugs could hold

Study details and key findings

For the study, researchers analyzed the health records of over 2 million patients with diabetes in the Veterans Affairs database. Among the patients, 215,970 were taking GLP-1 drugs while the remainder received other diabetes drugs and usual care. Between October 2017 and December 2023, the researchers tracked patients’ outcomes for 175 different health conditions.

Overall, the researchers found that patients who took GLP-1 drugs had lower risks...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Provider, Survey / Study, Trends
Which Biopharma Startups Made the Cut for INVEST Pitch Perfect?
PBMs push private-label biosimilars in 2025 formularies
CAR T-Cell Pioneer Plots Technology’s Next Steps
Eli Lilly Adds Alzheimer’s Care to Digital Health Platform Services
GLP-1 drug use for weight loss has soared, costing billions

Share This Article